Background
DISEASE, RESPIRATORY INSUFFICIENCY, INFLAMMATORY RESPONSE
Edited by: Gerardo Guillen, Center for Genetic Engineering and Biotechnology (CIGB), CubaReviewed by: Marko Lucijanic, Clinical Hospital Dubrava, Croatia; Massimiliano Bonifacio, University of Verona, Italy†These authors have contributed equally to this workThis article was submitted to Cytokines and Soluble Mediators in Immunity, a section of the journal Frontiers in ImmunologyManaging the inflammatory response to SARS-Cov-2 could prevent respiratory insufficiency. Cytokine profiles could identify cases at risk of severe disease.